Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
This study reinforces the noninferiority of sentinel node biopsy in patients with clinically node-negative breast cancer, offering a potential paradigm shift in surgical decision-making and patient care.
Oncology, Medical April 8th 2024
UCSF MedConnection
Explore the potential of IS-002, an imaging agent that offers a new dimension in intraoperative prostate cancer detection, promising a more targeted approach to surgical intervention and patient management.
Oncology, Medical March 4th 2024
In a recent randomized trial comparing radical and simple hysterectomy in patients with low-risk cervical cancer, findings demonstrated that simple hysterectomy was not inferior in preventing pelvic recurrence at 3 years and offered a significant reduction in postoperative urinary complications.
Obstetrics & Gynecology March 4th 2024
In the KEYNOTE-564 trial, adjuvant pembrolizumab demonstrated a significant improvement in disease-free survival among patients with renal-cell carcinoma at high risk of recurrence after nephrectomy, offering a new direction in post-surgical treatment strategies.
Nephrology February 20th 2024
MDLinx
In the evolving landscape of surgical innovation, the da Vinci robotic system exemplifies both the potential and the challenges of integrating advanced technology into patient care, underscoring the critical need for rigorous training and safety protocols.
Internal Medicine February 20th 2024
Cancer Therapy Advisor
Recent findings from the ASCO Gastrointestinal Cancers Symposium 2024 underscore the potential of innovative therapeutic combinations in enhancing outcomes for hepatocellular carcinoma patients, particularly those with unresectable or high-risk disease.
Oncology, Medical February 12th 2024